Bennett Ma

2.0k total citations
38 papers, 1.6k citations indexed

About

Bennett Ma is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Bennett Ma has authored 38 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Bennett Ma's work include Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Bennett Ma is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Bennett Ma collaborates with scholars based in United States, Switzerland and Japan. Bennett Ma's co-authors include Thomayant Prueksaritanont, Jiunn H. Lin, Thomas A. Baillie, Paul G. Pearson, Yue Qiu, Lida Liu, Nathan X. Yu, Raju Subramanian, Xiaojun Fang and Cuyue Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Bennett Ma

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bennett Ma United States	16	616	489	467	356	194	38	1.6k
Aleksi Tornio Finland	25	883 1.4×	307 0.6×	615 1.3×	295 0.8×	171 0.9×	68	1.9k
Kamlesh P. Vyas United States	26	854 1.4×	385 0.8×	494 1.1×	606 1.7×	211 1.1×	58	2.3k
Jenny Y. Chien United States	23	479 0.8×	285 0.6×	327 0.7×	951 2.7×	212 1.1×	48	2.2k
Robert Elsby United Kingdom	20	551 0.9×	224 0.5×	729 1.6×	367 1.0×	111 0.6×	25	1.6k
David R. Plowchalk United States	20	330 0.5×	187 0.4×	264 0.6×	270 0.8×	114 0.6×	27	1.4k
Yue Qiu China	12	247 0.4×	550 1.1×	233 0.5×	185 0.5×	99 0.5×	25	1.1k
Michael Pacanowski United States	21	319 0.5×	349 0.7×	105 0.2×	249 0.7×	135 0.7×	66	1.3k
Lloyd R. Whitfield United States	19	216 0.4×	359 0.7×	325 0.7×	222 0.6×	105 0.5×	48	1.2k
Jouko Laitila Finland	25	1.0k 1.6×	250 0.5×	845 1.8×	371 1.0×	85 0.4×	33	2.1k
Pei Hu China	26	392 0.6×	229 0.5×	589 1.3×	778 2.2×	72 0.4×	222	2.6k

Countries citing papers authored by Bennett Ma

Since Specialization

Citations

This map shows the geographic impact of Bennett Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bennett Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bennett Ma more than expected).

Fields of papers citing papers by Bennett Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bennett Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bennett Ma. The network helps show where Bennett Ma may publish in the future.

Co-authorship network of co-authors of Bennett Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Bennett Ma. A scholar is included among the top collaborators of Bennett Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bennett Ma. Bennett Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Layton, M. E., Jeffrey C. Kern, William D. Shipe, et al.. (2023). Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia. Journal of Medicinal Chemistry. 66(2). 1157–1171. 22 indexed citations

Paone, Daniel V., Kausik K. Nanda, Jing Li, et al.. (2022). Lead optimization of cathepsin K inhibitors for the treatment of Osteoarthritis. Bioorganic & Medicinal Chemistry Letters. 74. 128927–128927. 6 indexed citations

Ma, Bennett, et al.. (2021). Reaction Phenotyping of Low-Turnover Compounds in Long-Term Hepatocyte Cultures Through Persistent Selective Inhibition of Cytochromes P450. Drug Metabolism and Disposition. 49(11). 995–1002. 10 indexed citations

Ma, Bennett, et al.. (2018). Establishment of intracellular tenofovir-diphosphate as the key determinant for in vitro-in vivo translation of antiviral efficacy. Antiviral Research. 151. 1–3. 2 indexed citations

Ma, Bennett, Bin Luo, Gregg Wesolowski, et al.. (2017). Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(4). 435–441. 9 indexed citations

Ma, Bennett, et al.. (2016). Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction. European Journal of Drug Metabolism and Pharmacokinetics. 42(2). 319–326. 4 indexed citations

Pokorny, Jenny L., David Calligaris, Shiv K. Gupta, et al.. (2015). The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood–Brain Barrier in Glioblastoma. Clinical Cancer Research. 21(8). 1916–1924. 71 indexed citations

Brandish, Philip E., Thomas Forest, Sylvain Molon-Noblot, et al.. (2009). Eplerenone Decreases Inflammatory Foci in Spontaneously Hypertensive Rat Hearts With Minimal Effects on Blood Pressure. Journal of Cardiovascular Pharmacology. 53(1). 44–51. 7 indexed citations

Wolkenberg, S. E., Zhijian Zhao, David D. Wisnoski, et al.. (2009). Discovery of GlyT1 inhibitors with improved pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 19(5). 1492–1495. 15 indexed citations

10.

Tang, Cuyue, Brian Carr, Bennett Ma, et al.. (2008). CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3′-fluoro-4′-{(1 R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a Bradykinin B1 Receptor Antagonist. Journal of Pharmacology and Experimental Therapeutics. 325(3). 935–946. 6 indexed citations

11.

Ma, Bennett, et al.. (2007). Cytochrome P450 3A-Dependent Metabolism of a Potent and Selective γ-Aminobutyric AcidAα2/3 Receptor Agonist in Vitro: Involvement of Cytochrome P450 3A5 Displaying Biphasic Kinetics. Drug Metabolism and Disposition. 35(8). 1301–1307. 9 indexed citations

12.

Ma, Bennett & F.N. Chang. (2007). Purification and cloning of a Delta class glutathioneS‐transferase displaying high peroxidase activity isolated from the German cockroachBlattella germanica. FEBS Journal. 274(7). 1793–1793. 22 indexed citations

13.

Prueksaritanont, Thomayant, Jerome Hochman, Meng Yuan, et al.. (2004). Renal elimination of a novel and potent α_vβ₃integrin antagonist in animals. Xenobiotica. 34(11-12). 1059–1074. 6 indexed citations

14.

Prueksaritanont, Thomayant, Bennett Ma, & Nathan X. Yu. (2003). The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6. British Journal of Clinical Pharmacology. 56(1). 120–124. 145 indexed citations

15.

Tang, Cuyue, Jerome Hochman, Bennett Ma, Raju Subramanian, & Kamlesh P. Vyas. (2003). Acyl Glucuronidation and Glucosidation of a New and Selective Endothelin ETA Receptor Antagonist in Human Liver Microsomes. Drug Metabolism and Disposition. 31(1). 37–45. 35 indexed citations

16.

Ma, Bennett, Magang Shou, & Michael Schrag. (2003). SOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITRO. Drug Metabolism and Disposition. 31(11). 1300–1305. 30 indexed citations

17.

Prueksaritanont, Thomayant, Raju Subramanian, Xiaojun Fang, et al.. (2002). Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization. Drug Metabolism and Disposition. 30(5). 505–512. 276 indexed citations

18.

Prueksaritanont, Thomayant, Jamie J. Zhao, Bennett Ma, et al.. (2002). Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins. Journal of Pharmacology and Experimental Therapeutics. 301(3). 1042–1051. 219 indexed citations

19.

Prueksaritanont, Thomayant, Meng Yuan, Bennett Ma, et al.. (2002). Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of α v β 3 - antagonists in rat: limited role of P-glycoprotein. Xenobiotica. 32(3). 207–220. 9 indexed citations

20.

Prueksaritanont, Thomayant, Bennett Ma, Cuyue Tang, et al.. (1999). Metabolic interactions between mibefradil and HMG‐CoA reductase inhibitors: an in vitro investigation with human liver preparations. British Journal of Clinical Pharmacology. 47(3). 291–298. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact